Chronic thromboembolic pulmonary hypertension
Tidsskr Nor Laegeforen. 2025 Mar 18;145(4).
doi: 10.4045/tidsskr.24.0508.
Print 2025 Mar 25.
[Article in
English,
Norwegian]
Authors
John-Peder Escobar Kvitting
1
, Håvard Ravnestad
2
, Rune Andersen
3
, Eyvind Gjønnæss
3
, Natasha Moe
3
, Sigurd Birkeland
4
, Morten Svalebjørg
5
, Per Snorre Lingaas
4
, Einar Gude
2
, Lars Gullestad
6
, Kaspar Broch
2
, Arne K Andreassen
2
Affiliations
- 1 Thoraxkirurgisk avdeling, Oslo universitetssykehus, Rikshospitalet, og, Institutt for klinisk medisin, Universitetet i Oslo.
- 2 Kardiologisk avdeling, Oslo universitetssykehus, Rikshospitalet.
- 3 Radiologisk avdeling, Oslo universitetssykehus, Rikshospitalet.
- 4 Thoraxkirurgisk avdeling, Oslo universitetssykehus, Rikshospitalet.
- 5 Akuttklinikken, Oslo universitetssykehus, Rikshospitalet.
- 6 Kardiologisk avdeling, Oslo universitetssykehus, Rikshospitalet, og, Institutt for klinisk medisin, Universitetet i Oslo.
Abstract
Chronic thromboembolic pulmonary hypertension is a rare complication of pulmonary embolism and entails high morbidity and mortality. The gold standard for treatment is pulmonary endarterectomy, which improves haemodynamics and exercise capacity, and is potentially curative. Alternative options for the approximately one third of patients who are inoperable are percutaneous balloon pulmonary angioplasty and medical therapy. The aim of this article is to provide a clinical overview of the pharmacological, endovascular and surgical treatments for the condition.
MeSH terms
-
Angioplasty, Balloon
-
Antihypertensive Agents / therapeutic use
-
Chronic Disease
-
Endarterectomy
-
Humans
-
Hypertension, Pulmonary* / diagnosis
-
Hypertension, Pulmonary* / drug therapy
-
Hypertension, Pulmonary* / etiology
-
Hypertension, Pulmonary* / surgery
-
Hypertension, Pulmonary* / therapy
-
Pulmonary Embolism* / complications
-
Pulmonary Embolism* / drug therapy
-
Pulmonary Embolism* / surgery
-
Pulmonary Embolism* / therapy